Medication Fact Sheets
|
December 24, 2024

Vilazodone Guide: Uses, Benefits, Safety, and Administration

Written By
Dr. Ayesha Bryant MSPH, MD
Medically Reviewed by
Updated On
January 8, 2025

Antidepressants play a vital role in treating mental health conditions, helping millions manage symptoms of depression and anxiety. 

Among them, vilazodone is notable for its dual-action mechanism, combining selective serotonin reuptake inhibition with serotonin receptor modulation. This mechanism may provide an alternative for individuals exploring different treatment options.

This article explores vilazodone’s uses, benefits, side effects, and its essential role in addressing depression and anxiety disorders.

[signup]

What is Vilazodone?

Vilazodone (Viibryd) is a prescription medication used to treat major depressive disorder (MDD) in adults. It is classified as a selective serotonin reuptake inhibitor (SSRI), but it also acts as a partial agonist of serotonin receptors, making it unique among antidepressants. 

Overview of Vilazodone

Vilazodone is prescribed to help manage symptoms of depression, such as persistent sadness, lack of interest in activities, and difficulty concentrating. Unlike traditional SSRIs, it has a dual-action mechanism that may provide an additional therapeutic option for some patients.

Key Features:

  • Treats major depressive disorder (MDD).
  • Dual action: Combines SSRI activity with partial serotonin receptor agonism.
  • Typically taken once daily, often with food to improve absorption.

History and Development of Vilazodone

Vilazodone was first synthesized in the 1990s, and years of research and clinical trials were conducted to test its safety and effectiveness. It was developed to improve treatment for depression, focusing on enhancing serotonin activity more comprehensively than older antidepressants.

FDA Approval and Unique Mechanism of Action

In 2011, the U.S. Food and Drug Administration (FDA) approved Vilazodone to treat MDD. Vilazodone's approval highlighted its dual-action mechanism, setting it apart from standard SSRIs. It works by:

  • Inhibiting serotonin reuptake, which increases serotonin levels in the brain.
  • Acting as a partial agonist at serotonin receptors, enhancing the mood-regulating effects of serotonin.

This combination may support mood stabilization and symptom management in individuals with depression.

How Vilazodone Works

Vilazodone boosts serotonin levels, a key brain chemical involved in mood regulation. Inhibiting serotonin reuptake ensures more of the chemical remains available to nerve cells. Its receptor agonism may contribute to the overall therapeutic effect for some individuals.

SSRI Function and Serotonin Modulation

  • SSRIs like vilazodone work by stopping the brain from reabsorbing serotonin too quickly.
  • Serotonin receptor agonism further enhances mood stability.

Comparison to Other Antidepressants

While vilazodone shares similarities with SSRIs like fluoxetine or sertraline, its receptor-targeting ability is unique. This could mean:

Uses and Benefits of Vilazodone

Vilazodone has gained attention for its dual-action mechanism, which combines the benefits of selective serotonin reuptake inhibition and serotonin receptor modulation. This unique approach targets depressive symptoms and provides additional therapeutic advantages over traditional antidepressants.

Treating Major Depressive Disorder (MDD)

Clinical studies suggest that vilazodone may help improve mood and overall functioning in individuals with depression. While individual responses vary, it may be considered when other antidepressants have not provided sufficient relief.

Clinical Effectiveness:

  • Improves mood and energy levels by increasing serotonin activity.
  • It is particularly helpful in cases where traditional SSRIs fall short.

Though individual patient testimonials are varied, many report fewer side effects, contributing to its growing popularity in managing depression.

Anxiety Management

While vilazodone is not officially approved for treating anxiety disorders, some healthcare providers prescribe it off-label for conditions like generalized anxiety disorder (GAD) or social anxiety. Its unique mechanism, which modulates serotonin receptors, may help manage anxiety symptoms in certain patients.

Comparisons with Other Treatments:

  • Traditional SSRIs like sertraline and paroxetine are widely used but may take longer to show results.
  • Vilazodone’s receptor modulation may contribute to faster relief of anxiety symptoms.

Advantages Over Traditional Antidepressants

Vilazodone offers several potential benefits that make it an appealing choice for patients:

  • Faster Onset of Action: Studies suggest that vilazodone may offer an alternative to conventional SSRIs for some individuals, though response times vary.
  • Reduced Sexual Side Effects: Many antidepressants are associated with sexual dysfunction, but research shows vilazodone has a lower risk of this side effect, improving patient satisfaction and adherence to treatment.

Dosage and Administration

Proper dosing of vilazodone is important to its intended use and safety. Always follow your healthcare provider’s instructions when taking this medication.

Standard Dosage Guidelines

The typical dosage of vilazodone varies based on individual needs and the stage of treatment.

  • Starting Dose: Most adults begin with 10 mg taken once daily with food for the first 7 days.
  • Dose Adjustment: After the initial week, the dose is often increased to 20 mg daily. If necessary, it may be adjusted further to 40 mg daily, depending on the patient’s response and tolerance.
  • Maximum Dose: 40 mg per day is the highest recommended dose.

Gradual adjustments allow the body to adapt and minimize side effects like nausea or dizziness.

How to Take Vilazodone Safely

For vilazodone to work effectively, it must be taken as directed by your doctor. Here are some tips to ensure safe and proper use:

Take with Food

  • Why It Matters: Vilazodone’s absorption is enhanced when taken with food, ensuring that the correct amount of medication enters your bloodstream.
  • Tip: Schedule your dose with a meal or snack to make it a daily habit.

Avoid Common Mistakes

  • Skipping Doses: Missing doses can reduce effectiveness or cause withdrawal-like symptoms. Use reminders or alarms to stay consistent.
  • Abruptly Stopping: Do not stop taking vilazodone suddenly. This can lead to unpleasant withdrawal effects like dizziness or mood swings. Always consult your doctor before discontinuing.
  • Alcohol and Other Medications: Avoid alcohol and discuss other drugs or supplements you’re taking, as interactions can affect vilazodone’s safety.

Side Effects and Precautions

Like any medication, vilazodone can cause side effects. While many are mild and manageable, some require immediate medical attention. Understanding these effects and taking necessary precautions is essential for safe use.

Common Side Effects

Most people taking vilazodone experience mild to moderate side effects, especially during the initial weeks of treatment. These include:

  • Gastrointestinal Issues: Nausea, diarrhea, and vomiting are the most commonly reported symptoms.
  • Sleep Disturbances: Some patients may experience insomnia or unusual dreams.
  • Other Symptoms: Dizziness, dry mouth, and fatigue have also been noted.

These side effects may decrease over time as the body adjusts to the medication. If they persist or worsen, consult a healthcare provider.

Rare But Serious Risks

Although uncommon, some side effects are more severe and require urgent attention:

  • Serotonin Syndrome: This rare but potentially serious condition may occur if serotonin levels in the brain become elevated. Symptoms include confusion, rapid heart rate, fever, and muscle rigidity.
  • Suicide Risk in Younger Populations: As with many antidepressants, vilazodone may increase the risk of suicidal thoughts in young adults, teens, and children, particularly when starting treatment or adjusting the dose.

Drug Interactions and Warnings

Certain medications can interact with vilazodone, increasing the risk of side effects or reducing its effectiveness.

  • Monoamine oxidase inhibitors (MAOIs): Combining vilazodone with MAOIs can lead to serotonin syndrome. A minimum 14-day gap is necessary when switching between these drugs.
  • Blood Thinners: Caution is advised when using medications like aspirin or warfarin, as vilazodone may increase bleeding risk.

Always inform your doctor about all drugs and supplements you’re taking.

Contraindications and Safety in Pregnancy:

Vilazodone may not be recommended during pregnancy unless the potential benefits outweigh the risks. It may pose risks to the developing fetus. It’s also unclear if vilazodone passes into breast milk, so caution is advised for breastfeeding mothers.

Frequently Asked Questions

Below are some frequently asked questions:

Can Vilazodone Be Combined with Other Medications?

Vilazodone can sometimes be used alongside other medications, but it requires careful management to avoid drug interactions.

  • Polypharmacy Guidance: Patients taking multiple medications should consult their healthcare provider to assess compatibility. Combining vilazodone with other antidepressants, antianxiety drugs, or mood stabilizers may increase the risk of side effects, including serotonin syndrome.
  • Avoid combining vilazodone with monoamine oxidase inhibitors (MAOIs). A 14-day gap is essential if switching between these drugs.
  • Be cautious with blood thinners (e.g., aspirin or warfarin) as they may increase the risk of bleeding.

How Long Does Vilazodone Take to Work?

The timeline for vilazodone's therapeutic effects varies but typically follows these general guidelines:

  • First Few Weeks: Some patients notice mild improvements in energy and sleep patterns within the first 1–2 weeks. However, it may take time for significant mood improvements to become evident.
  • Full Effect: For many people, vilazodone may take 4–8 weeks to achieve its intended therapeutic effect. Consistent use is critical during this period, even if results are not immediately apparent.

Is Vilazodone Right for Me?

Choosing vilazodone as a treatment option depends on individual health needs and medical history.

Key Considerations:

  • It may be particularly beneficial for patients who have not responded well to traditional SSRIs or those who experience intolerable side effects from other antidepressants.
  • Discuss your full medical history, including any past experiences with depression medications, with your healthcare provider.

Alternative Options: If vilazodone is not suitable, other treatments such as SSRIs (e.g., sertraline or fluoxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs), or even therapy and lifestyle modifications may be explored.

By working closely with a healthcare provider, patients can determine whether vilazodone is the right fit for their treatment plan, ensuring the best possible outcomes.

[signup]

Key Takeaways

  • Unique Dual Action: Vilazodone combines selective serotonin reuptake inhibition with serotonin receptor modulation, offering a distinct approach to treating major depressive disorder (MDD).
  • Effectiveness and Benefits: It may help manage depressive symptoms and has been associated with fewer sexual side effects compared to some traditional antidepressants.
  • Side Effects and Precautions: Common side effects include nausea, diarrhea, and sleep disturbances. Rare but serious risks include serotonin syndrome and increased suicide risk in younger populations.
  • Dosage and Administration: Proper dosing starts with 10 mg daily, typically taken with food to enhance absorption, and gradually increases to a maximum of 40 mg per day.
  • Patient Considerations: Vilazodone is suitable for some individuals with MDD or off-label for anxiety, but careful management is needed to avoid drug interactions. Consultation with a healthcare provider ensures safe and effective use.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Bixby, A. L., VandenBerg, A., & Bostwick, J. R. (2018). Clinical Management of Bleeding Risk With Antidepressants. Annals of Pharmacotherapy, 53(2), 186–194. https://doi.org/10.1177/1060028018794005

Celada, P., Bortolozzi, A., & Artigas, F. (2013). Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research. CNS Drugs, 27(9), 703–716. https://doi.org/10.1007/s40263-013-0071-0

Chu, A., & Wadhwa, R. (2023, May 1). Selective Serotonin Reuptake Inhibitors. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554406/

Cleveland Clinic. (2023, August 30). Antidepressant Discontinuation Syndrome. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/25218-antidepressant-discontinuation-syndrome

Cloyd, J. (2023, August 25). A Root Cause Medicine Protocol For Patients With Insomnia: Testing, Therapeutic Diet, and Supportive Supplements. Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-protocol-for-patients-with-insomnia-testing-therapeutic-diet-and-supportive-supplements

Croft, H. A., Pomara, N., Gommoll, C., Chen, D., Nunez, R., & Mathews, M. (2014). Efficacy and Safety of Vilazodone in Major Depressive Disorder. The Journal of Clinical Psychiatry, 75(11), e1291–e1298. https://doi.org/10.4088/jcp.14m08992

Diorio, B. (2022, September 6). How to increase your serotonin levels naturally. Rupa Health. https://www.rupahealth.com/post/how-to-increase-your-serotonin-naturally

John Hopkins Medicine. (2019). Generalized Anxiety Disorder (GAD). John Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/generalized-anxiety-disorder

Khan, A., Durgam, S., Tang, X., Ruth, A., Mathews, M., & Gommoll, C. P. (2016). Post Hoc Analyses of Anxiety Measures in Adult Patients With Generalized Anxiety Disorder Treated With Vilazodone. The Primary Care Companion for CNS Disorders. https://doi.org/10.4088/pcc.15m01904

Kresge, K. (2023, February 21). An Integrative Medicine Approach to Depression. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-depression

Liebowitz, M., Croft, H. A., Kajdasz, D. K., Whalen, H., Gallipoli, S., Athanasiou, M., & Reed, C. R. (2011). The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder. Psychopharmacology Bulletin, 44(3), 15. https://pmc.ncbi.nlm.nih.gov/articles/PMC5044546/

Maholy, N. (2023, February 17). A functional medicine approach to anxiety: Testing, nutrition, & supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-anxiety

Mathews, M., Gommoll, C., Chen, D., Nunez, R., & Khan, A. (2015). Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder. International Clinical Psychopharmacology, 30(2), 67–74. https://doi.org/10.1097/yic.0000000000000057

National Alliance on Mental Illness. (2024, April 17). Vilazodone (Viibryd). NAMI. https://www.nami.org/about-mental-illness/treatments/mental-health-medications/types-of-medication/vilazodone-viibryd/

NIH. (2023). DailyMed - VIIBRYD- vilazodone hydrochloride tablet VIIBRYD- vilazodone hydrochloride kit. Nih.gov. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c55ccfb-c4cf-11df-851a-0800200c9a66

Patel, S., Preuss, C. V., Bhutani, J., & Patel, N. (2024, October 5). Warfarin. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470313/

Pierz, K. A., & Thase, M. E. (2014). A Review of Vilazodone, Serotonin, and Major Depressive Disorder. The Primary Care Companion for CNS Disorders. https://doi.org/10.4088/pcc.13r01554

Sansone, R. A., & Sansone, L. A. (2014). Serotonin Norepinephrine Reuptake Inhibitors: A Pharmacological Comparison. Innovations in Clinical Neuroscience, 11(3-4), 37. https://pmc.ncbi.nlm.nih.gov/articles/PMC4008300/

Schwartz, T. L., Siddiqui, U. A., & Stahl, S. M. (2011). Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor. Therapeutic Advances in Psychopharmacology, 1(3), 81–87. https://doi.org/10.1177/2045125311409486

Shrestha, P., & Abdijadid, S. (2023, July 17). Paroxetine. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK526022/

Singh, H. K., & Saadabadi, A. (2023). Sertraline. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK547689/

Volpi-Abadie, J., Kaye, A. M., & Kaye, A. D. (2024). Serotonin Syndrome. The Ochsner Journal, 13(4), 533. https://pmc.ncbi.nlm.nih.gov/articles/PMC3865832/

Yoshimura, H. (2023, September 6). Top Labs To Run Bi-Annually On Your Patients Who Suffer From Major Depressive Disorder. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-patients-who-suffer-from-major-depressive-disorder

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.